Cardio Diagnostics Holdings Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Cardio Diagnostics Holdings Inc..
Log in to see more information.

News

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Increase in Short Interest
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Increase in Short Interest

Ticker Report Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO - Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest...\n more…

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Drop in Short Interest
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Drop in Short Interest

Ticker Report Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO - Get Free Report) was the recipient of a significant drop in short interest during the month of July. As of July 31st, there was short interest...\n more…

CDIO Stock Earnings: Cardio Diagnostics Hldgs Beats EPS, Misses Revenue for Q2 2024
CDIO Stock Earnings: Cardio Diagnostics Hldgs Beats EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nCDIO stock results show that Cardio Diagnostics Hldgs beat analyst estimates for earnings per share but missed on revenue for the second...\n more…

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Business Wire Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its redesigned website at CDIO.AI. This new site emphasizes...\n more…

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois
Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Business Wire Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Companys clinical blood test, Epi+Gen CHD is now available at Family...\n more…

CDIO Stock Earnings: Cardio Diagnostics Hldgs Misses EPS, Misses Revenue for Q1 2024
CDIO Stock Earnings: Cardio Diagnostics Hldgs Misses EPS, Misses Revenue for Q1 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nCDIO stock results show that Cardio Diagnostics Hldgs missed analyst estimates for earnings per share and missed on revenue for the...\n more…